/Investors

OVP Venture Partners

Venture capital

Seattle · Pre-Seed–Late Stage · 1 people tracked

Find your way into OVP Venture Partners

1 people in our graph share verified history with the OVP Venture Partners team — schools, employers, funds. One of them is your warm intro.

✨ Fox Verdict
Sign up to see your fit
Stage
Pre-Seed–Late Stage
HQ
Seattle, Washington, US
Founded
1983
Tracked investments
4
IPOs
1

Team · 1 people

from public directories
Chad Waitein

What they invest in

from 2 of 4 portfolio companies

Biotech ×1Cleantech ×1Digital Health ×1Energy ×1Hardware ×1Healthtech ×1Medical Devices ×1New Materials ×1

HQs:United States×4

Investments · 4 tracked

founders shown can be your intro path
Fate Therapeuticsfatetherapeutics.comNASDAQ: FATE

Fate Therapeutics develops investigational cellular immunotherapies to treat autoimmune diseases and cancer.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Christian Weyer(Executive Officer, Director)J. Scott Wolchko(Executive Officer)Daniel Shoemaker(Executive Officer)inBahram (Bob) Valamehr(President & Chief Executive Officer)inBahram Valamehr(President, Chief Executive Officer, and Director)in

BoardAmir Nashat(Director)in

Co-investorsSanofi VenturesVenrockFidelity InvestmentsPolaris Partners

Group14 Technologiesgroup14.technologyin𝕏✓ verified

Group14 develops silicon battery materials, specifically SCC55®, for automotive and consumer electronics manufacturers.

CleantechEnergyHardwareNew MaterialsWoodinville, US

Henry Costantino(Executive Officer)Rick LuebbeinDr. Rick CostantinoJohn Reagh(Director)Eric Luebbe(Executive Officer, Director, Promoter)Bill Funcannon(Director)

Co-investorsBASF Venture Capital GmbHEarth Venture CapitalMetaplanetSalviaVsquared VenturesYaletown Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AdapxPen Technology

Exits · 1

1 IPOs

Fate TherapeuticsNASDAQ: FATE

Fund performance · per public LP disclosures · 5

as of Sep 2025
FundVintageCommittedNet IRRTVPIDPI
OVP Venture Partners VII, L.P.LPs: Oregon Public Employees Retirement System, Washington State Investment Board2006—-2.2%0.79x0.79x
OVP Venture Partners VI, L.P.LPs: Oregon Public Employees Retirement System, Washington State Investment Board2001—-15.6%0.30x0.28x
Olympic Venture Partners VLPs: Oregon Public Employees Retirement System2000—-16.7%0.27x0.27x
Olympic Venture Partners IVLPs: Oregon Public Employees Retirement System1997—63.9%2.62x2.62x
Olympic Venture Partners IIILPs: Oregon Public Employees Retirement System1994—27.1%2.22x2.23x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

IPO stake values · per SEC filings

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Fate Therapeutics7.8%$6.00Oct 2013$9M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

What stage does OVP Venture Partners invest at?
OVP Venture Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Late Stage stages.
What sectors does OVP Venture Partners focus on?
OVP Venture Partners focuses on Consumer, Crypto & Web3, Fintech, SaaS.
Where is OVP Venture Partners located?
OVP Venture Partners is headquartered in Seattle, US.

Similar investors

Featured in lists